From: The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells
Drugs
MCF-7
ZR75-1
Ratio
Tamoxifen : Paclitaxel
5:3
4:3
Tamoxifen : Docetaxel
Fulvestrant : Paclitaxel
5:4
1:1
Fulvestrant : Docetaxel